CoChat

Outcome markers for clinical trials in cerebral amyloid angiopathy

Open access
Greenberg, Steven M, Salman, Rustam Al-Shahi, Biessels, Geert Jan, van Buchem, Mark, Cordonnier, Charlotte, Lee, Jin-Moo, Montaner, Joan, Schneider, Julie A, Smith, Eric E, Vernooij, Meike, Werring, David J · 2014 · The Lancet Neurology
Cited by 147

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Efforts are underway for early-phase trials of candidate therapies for cerebral amyloid angiopathy (CAA), an untreatable cause of hemorrhagic stroke and vascular cognitive impairment. A major barrier to these trials is the lack of consensus on measuring treatment effectiveness. We review a range of potential outcome markers for CAA against the ideal criteria of being clinically meaningful, closely reflective of biological progression, efficient for smaller/shorter trials, reliably measurable, and cost effective. In practice, outcomes tend either to have high clinical salience but relatively low statistical efficiency and thus more applicability for later phase studies, or greater statistical efficiency but more limited clinical meaning. The most statistically efficient outcomes are those that are potentially reversible with treatment, though their clinical significance remains unproven. Many of the candidate outcomes for CAA trials are likely to be applicable to other small vessel brain diseases as well. Considerations emerging from this review outline a path towards rapid and efficient testing of emerging candidate therapies for CAA and other small vessel diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70003-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 147

Metadata

Authors
Greenberg, S. M., Salman, R. A.-S., Biessels, G. J., van Buchem, M., Cordonnier, C., Lee, J.-M., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M., & Werring, D. J.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2014-04
Volume
13
Issue
4
Pages
419-428
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2125469441
Cited by
147
References
37
FWCI
11.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome markers for clinical trials in cerebral amyloid angiopathy. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70003-1
The paper
Greenberg, S. M., Salman, R. A.-S., Biessels, G. J., van Buchem, M., Cordonnier, C., Lee, J.-M., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M., & Werring, D. J. (2014). Outcome markers for clinical trials in cerebral amyloid angiopathy. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70003-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.